Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow tract (LVOT) gradient, a measure of ...
Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow tract (LVOT) gradient, a measure of ...
Please provide your email address to receive an email when new articles are posted on . Two weeks of metoprolol improved left ventricular outflow tract gradients, symptoms and quality of life compared ...
TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy Receive the the latest news, research, and presentations from major ...
Credit: Getty Images HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C. Hypertrophic cardiomyopathy (HCM) ...
Dr. David M. Dudzinski: A 78-year-old man was evaluated in the cardiology clinic of this hospital because of biventricular myocardial wall thickening, progressive mitral regurgitation, and ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results